Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kadmon Holdings Inc. (KDMN)

4.73   0.15 (3.28%) 07-07 16:00
Open: 4.56 Pre. Close: 4.58
High: 4.9 Low: 4.5393
Volume: 2,125,601 Market Cap: 757M
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Its lead product candidates include KD025, an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2, which is in Phase II clinical trial for the treatment of chronic graft-versus-host and fibrotic diseases; KD045, an oral inhibitor of ROCK for the treatment of fibrotic diseases; and KD033, an anti-PD-L1/IL-15 fusion protein for the treatment of cancer. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease. Kadmon Holdings, Inc. has strategic collaborations and license agreements with Nano Terra, Inc. and Dyax Corp.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.911 - 4.944 4.944 - 4.973
Low: 4.463 - 4.503 4.503 - 4.539
Close: 4.668 - 4.731 4.731 - 4.789

Technical analysis

as of: 2020-07-07 4:35:55 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.84     One year: 6.42
Support: Support1: 4.18    Support2: 3.48
Resistance: Resistance1: 5.00    Resistance2: 5.50
Pivot: 4.89
Moving Average: MA(5): 4.79     MA(20): 4.82
MA(100): 4.36     MA(250): 3.78
MACD: MACD(12,26): 0.08     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 26.49     %D(3): 33.43
RSI: RSI(14): 49.16
52-week: High: 5.50  Low: 2.04  Change(%): 100.4
Average Vol(K): 3-Month: 250423  10-Days: 314796

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
KDMN has closed above bottom band by 34.6%. Bollinger Bands are 12.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 06 Jul 2020
Kadmon Holdings, Inc. (KDMN) At $4.81: It’s Worth Your Interest - Stocks Register

Mon, 06 Jul 2020
Kadmon Holdings Inc. (KDMN) return on Assets touches -32.08: These Shares are Poised for Major Movement - News Daemon

Wed, 01 Jul 2020
Kadmon Holdings, Inc. (KDMN) and the Battle of Fundamental vs. Technical - The News Heater

Tue, 30 Jun 2020
When Will Kadmon Holdings, Inc. (NYSE:KDMN) Breakeven? - Simply Wall St

Mon, 29 Jun 2020
Learn Why Kadmon Holdings, Inc. (KDMN) Has Been Active In the Market Recently - Invest Million

Thu, 25 Jun 2020
Kadmon Holdings, Inc. (KDMN): Skating on Thin Ice? Beta Stands at 1.47 - The News Heater

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 160
Shares Float (M) 110
% Held by Insiders 0.16
% Held by Institutions 83.14
Shares Short (K) 19,290
Shares Short P. Month (K) 20,150

Stock Financials

EPS -0.690
EPS Est This Year -1.550
EPS Est Next Year -1.750
Book Value (p.s.) 0.600
Profit Margin
Operating Margin -701.10
Return on Assets (ttm) -27.1
Return on Equity (ttm) -72.0
Qtrly Rev. Growth 9952.2
Gross Profit (p.s.) 0.024
Sales Per Share 0.074
EBITDA (p.s.) -0.508
Qtrly Earnings Growth
Operating Cash Flow (M) -76
Levered Free Cash Flow (M) -46

Stock Valuations

PE Ratio -6.86
PEG Ratio
Price to Book value 7.88
Price to Sales 64.29
Price to Cash Flow -9.98

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.